Literature DB >> 33181064

Celebrating Rosalind Franklin's Centennial with a Nobel Win for Doudna and Charpentier.

Nicole M Gaudelli1, Alexis C Komor2.   

Abstract

Year:  2020        PMID: 33181064      PMCID: PMC7704750          DOI: 10.1016/j.ymthe.2020.11.013

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

Review 2.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

Authors:  Alexis C Komor; Ahmed H Badran; David R Liu
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

3.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.

Authors:  Nicole M Gaudelli; Alexis C Komor; Holly A Rees; Michael S Packer; Ahmed H Badran; David I Bryson; David R Liu
Journal:  Nature       Date:  2017-10-25       Impact factor: 49.962

4.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

5.  Search-and-replace genome editing without double-strand breaks or donor DNA.

Authors:  Andrew V Anzalone; Peyton B Randolph; Jessie R Davis; Alexander A Sousa; Luke W Koblan; Jonathan M Levy; Peter J Chen; Christopher Wilson; Gregory A Newby; Aditya Raguram; David R Liu
Journal:  Nature       Date:  2019-10-21       Impact factor: 69.504

  5 in total
  1 in total

1.  Case Study: CRISPR 101 - a novel online learning course harnessing innovative ways to teach a complex biomolecular technology.

Authors:  Martin Pal; Nicki Cranna; Marco J Herold; Keely Bumsted O'Brien
Journal:  Essays Biochem       Date:  2022-04-29       Impact factor: 8.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.